Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Reply to "Chaetocin is a nonspecific inhibitor of histone lysine methyltransferases"

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Greiner, D., Bonaldi, T., Eskeland, R., Roemer, E. & Imhof, A. Nat. Chem. Biol. 1, 143–145 (2006).

    Article  Google Scholar 

  2. Cherblanc, F.L., Chapman, K.L., Brown, R. & Fuchter, M.J. Nat. Chem. Biol. 9, 136–137 (2013).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The work has been supported by a predoctoral grant to D.G. from the School of Medicine from the Ludwig-Maximillians University of Munich (MolMed).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Axel Imhof.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Greiner, D., Bonaldi, T., Eskeland, R. et al. Reply to "Chaetocin is a nonspecific inhibitor of histone lysine methyltransferases". Nat Chem Biol 9, 137 (2013). https://doi.org/10.1038/nchembio.1188

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nchembio.1188

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research